Immunocore Holdings IMCR
NASDAQ IMCR
$30.29 -0.56 (-1.82%)
At close: Sep 30, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Receivables - Other (2019 - 2023)

Updated

Immunocore Holdings (IMCR) reported Receivables - Other of $6.91 million for Q2 2023.

Analysis

Immunocore Holdings (IMCR) Receivables - Other (2019 - 2023) Analysis & Trends

At the end of FY2022, Immunocore Holdings posted Receivables - Other of $9.01 million, up 345.5% from FY2021.

  • Receivables - Other has a three-year compound annual growth rate of 24.1% (FY2019 to FY2022).
  • By year, Receivables - Other came in at $2.02 million in FY2021 (-11.1%), $2.27 million in FY2020 (-51.8%) and $4.71 million in FY2019.
  • The Q2 2023 figure ranks as the lowest quarterly Receivables - Other since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Immunocore Holdings 1.59 Bn -1.89 Bn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 6.91 Mn
Dec 31, 2022 9.01 Mn
Sep 30, 2022 7.32 Mn
Dec 31, 2021 1.98 Mn
Dec 31, 2020 2.27 Mn
Dec 31, 2019 4.71 Mn
API Access

Immunocore Holdings Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=IMCR&period=max&api_key=YOUR_API_KEY